Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 44: 128132, 2021 07 15.
Artigo em Inglês | MEDLINE | ID: mdl-34022413

RESUMO

In our previous study, we had identified a 9-mer peptide (FSHß (89-97)) derived from seat belt loop of human FSHß and demonstrated its ability to function as FSHR antagonist in vivo. Structure analysis revealed that the four central residues 91STDC94 within this peptide may not be critical for receptor binding. In the present study, 91STDC94 residues were substituted with alanine to generate ΔFSHß 89-97(91STDC94/AAAA) peptide. Analogous to the parent peptide, ΔFSHß 89-97(91STDC94/AAAA) peptide inhibited binding of iodinated FSH to rat FSHR and reduced FSH-induced cAMP production. The peptide could impede granulosa cell proliferation leading to reduction in FSH-mediated ovarian weight gain in immature female rats. In these rats, peptide administration further downregulated androgen receptor and estrogen receptor-alpha expression and upregulated estrogen receptor-beta expression. The results indicate that substitution of 91STDC94 with alanine did not significantly alter FSHR antagonist activity of FSHß (89-97) peptide implying that these residues are not critical for FSH-FSHR interaction and can be replaced with non-peptidic moieties for development of more potent peptidomimetics.


Assuntos
Desenho de Fármacos , Hormônio Foliculoestimulante/farmacologia , Peptídeos/farmacologia , Peptidomiméticos , Receptores do FSH/antagonistas & inibidores , Animais , Sítios de Ligação/efeitos dos fármacos , Feminino , Hormônio Foliculoestimulante/química , Humanos , Modelos Moleculares , Ovário/efeitos dos fármacos , Peptídeos/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA